Congo, Democratic Republic of the vs Eswatini: Hypertension effective treatment coverage (controlled hypertension)
Congo, Democratic Republic of the
11.6%
in 2019
Eswatini
12.4%
in 2019
Congo, Democratic Republic of the rank
135th
Eswatini rank
134th
Hypertension effective treatment coverage (controlled hypertension) over time
- Congo, Democratic Republic of the
- Eswatini
How they compare
Eswatini currently reports 12.4% against 11.6% in Congo, Democratic Republic of the, a difference of 0.8%.
That makes Eswatini's figure about 1.1 times Congo, Democratic Republic of the's.
Across all 30 years both countries report, Eswatini has been ahead every year.
Congo, Democratic Republic of the ranks 135th and Eswatini ranks 134th of 193 countries.
Eswatini has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Congo, Democratic Republic of the | Eswatini | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 2.2% | 3.1% | 0.9% | Eswatini |
| 2000s | 4.1% | 5.6% | 1.5% | Eswatini |
| 2010s | 8.6% | 9.9% | 1.3% | Eswatini |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hypertension effective treatment coverage (controlled hypertension), Congo, Democratic Republic of the or Eswatini?
- Eswatini, at 12.4% against 11.6% in Congo, Democratic Republic of the as of 2019.
- What is the difference in hypertension effective treatment coverage (controlled hypertension) between Congo, Democratic Republic of the and Eswatini?
- 0.8%, with Eswatini ahead.
- How many years of comparable data are there for Congo, Democratic Republic of the and Eswatini?
- 30 years are reported by both, from 1990 to 2019.
- How do Congo, Democratic Republic of the and Eswatini rank globally for hypertension effective treatment coverage (controlled hypertension)?
- Congo, Democratic Republic of the ranks 135th and Eswatini ranks 134th of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hypertension effective treatment coverage (controlled hypertension )among adults aged 30-79, age-standardized (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.